Immediate Impact

57 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials
2024 Standout
2 intermediate papers

Works of Magnus Ekelund being referenced

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
2015

Author Peers

Author Last Decade Papers Cites
Magnus Ekelund 362 288 174 232 30 651
Alessandra Bertolotto 263 198 73 267 35 683
Emily D. Szmuilowicz 282 132 139 207 21 625
Ulysse Gaspard 260 122 146 112 47 821
Michele Aragona 298 247 102 141 35 718
Pablo Olmos 226 240 183 114 47 759
Naomi D Neufeld 217 213 129 62 36 588
Lois Jovanovič 454 289 189 285 26 813
Robert W. Lash 461 116 224 171 24 781
Susan Gelding 353 157 84 72 27 848
Kasper Pilgaard 218 185 177 164 28 694

All Works

Loading papers...

Rankless by CCL
2026